Menu

Blog

Archive for the ‘neuroscience’ category: Page 772

Nov 17, 2018

Michael Fossel — Defeating Aging

Posted by in categories: biotech/medical, education, ethics, life extension, neuroscience

https://www.youtube.com/attribution_link?a=P-wiCEov7oQ&u…ture=share

Michael B. Fossel, M.D., Ph.D. (born 1950, Greenwich, Connecticut) was a professor of clinical medicine at Michigan State University and is the author of several books on aging, who is best known for his views on telomerase therapy as a possible treatment for cellular senescence. Fossel has appeared on many major news programs to discuss aging and has appeared regularly on National Public Radio (NPR). He is also a respected lecturer, author, and the founder and former editor-in-chief of the Journal of Anti-Aging Medicine (now known as Rejuvenation Research).

Prior to earning his M.D. at Stanford Medical School, Fossel earned a joint B.A. (cum laude) and M.A. in psychology at Wesleyan University and a Ph.D. in neurobiology at Stanford University. He is also a graduate of Phillips Exeter Academy. Prior to graduating from medical school in 1981, he was awarded a National Science Foundation fellowship and taught at Stanford University.

In addition to his position at Michigan State University, Fossel has lectured at the National Institute for Health, the Smithsonian Institution, and at various other universities and institutes in various parts of the world. Fossel served on the board of directors for the American Aging Association and was their executive director.

Continue reading “Michael Fossel — Defeating Aging” »

Nov 17, 2018

Brain stimulation could let some blind people ‘see’ shapes made of light

Posted by in category: neuroscience

Sequential electrical stimulation allowed researchers to transmit complex patterns.

Read more

Nov 17, 2018

Is there any hope for resolving society’s deep disagreements?

Posted by in category: neuroscience

‘’Examining how deep disagreements arise will demonstrate the gravity of the issue. Why do we disagree with valid, knowable facts when we all live in the same world, we have roughly the same cognitive abilities and, in the Western world at least, most people have fairly easy access to roughly the same information?


What happens when you can’t agree on the facts?

Read more

Nov 17, 2018

Scorpion Venom Shuttles Drugs to the Brain

Posted by in categories: biotech/medical, neuroscience

And you thought needles were scary: Researchers are using scorpion venom to transport drugs to the brain.

The Peptides and Proteins lab at the Institute for Research in Biomedicine (IRB Barcelona) modified the amino acid chain chlorotoxin—present in scorpion venom—to carry medicine across humans’ blood-brain barrier (BBB).

An important mechanism for protecting the brain from harmful substances, the roadblock also prevents medication used to treat neurological diseases and tumors from entering the organ.

Continue reading “Scorpion Venom Shuttles Drugs to the Brain” »

Nov 16, 2018

Lab-Grown Mini Kidneys ‘Go Rouge,’ Sprout Brain and Muscle Cells

Posted by in categories: biotech/medical, neuroscience

Kidney organoids — miniature organs grown in the lab — recently went “rogue,” producing brain cells and muscle cells alongside the expected kidney cells.

Read more

Nov 15, 2018

Smartphones, tablets causing mental health issues in kids as young as two

Posted by in categories: health, mobile phones, neuroscience

Open a book kids!


Smartphones and tablets are causing issues for kids as young as two years old.

Read more

Nov 15, 2018

Flaws in industry-funded pesticide evaluation

Posted by in categories: food, health, neuroscience

The company-funded animal test was performed to ascertain how neural development is affected by the pesticide chlorpyrifos, which is used on a wide variety of crops around the world, including some 20 EU countries. The test laboratory concluded that there was no such effect, even at high doses.


Academic researchers have examined raw data from a company-funded safety evaluation of the pesticide chlorpyrifos. They discovered an effect on the brain architecture of the exposed laboratory animals at all tested doses, which was not included in the reported conclusions. Karolinska Institutet in Sweden led this independent study, which is published in the scientific journal Environmental Health.

All pesticides must be evaluated in terms of their safety and potential risks for human health before they can officially be approved. Normally the companies that manufacture the products cover the cost of such evaluations and commission test laboratories to perform the necessary animal tests.

Continue reading “Flaws in industry-funded pesticide evaluation” »

Nov 14, 2018

Reprogrammed cells could tackle brain damage

Posted by in category: neuroscience

Turning astrocytes into neurons improves symptoms in preliminary mouse studies.

Read more

Nov 14, 2018

Male and Female Brain Differences – Must We Keep Doing This?

Posted by in category: neuroscience

A recent large population study claims to conclusively prove that male and female brains are different. Of course, it does no such thing. As such, Dr Dean Burnett is quite annoyed.

Read more

Nov 14, 2018

Historic breakthrough: WVU Rockefeller Neuroscience team first to use ultrasound to treat Alzheimer’s

Posted by in categories: biotech/medical, neuroscience

MORGANTOWN — World-leading brain experts at West Virginia University’s Rockefeller Neuroscience Institute are celebrating the historic breakthrough Alzheimer patients around the global have been waiting for.

“For Alzheimer’s, there’s not that many treatments available despite hundreds of clinical trials over the past two decades and billions of dollars spent,” said Dr. Ali Rezai, a neurosurgeon at WVU who led the team of investigators that successfully performed a phase II trial using focused ultrasound to treat a patient with early stage Alzheimer’s.

The WVU team tested the innovative treatment in collaboration with INSIGHTEC, an Israeli medical technology company. Earlier this year, INSIGHTEC was approved by the U.S. Food and Drug Administration to begin a phase II clinical trial of the procedure and selected the WVU Rockefeller Neuroscience Institute as the first site in the United States for the trial.

Continue reading “Historic breakthrough: WVU Rockefeller Neuroscience team first to use ultrasound to treat Alzheimer’s” »